These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23467495)

  • 41. A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes.
    Shiraishi M; Sekiguchi A; Terry MJ; Oates AJ; Miyamoto Y; Chuu YH; Munakata M; Sekiya T
    Oncogene; 2002 May; 21(23):3804-13. PubMed ID: 12032849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylated CpG island amplification for methylation analysis and cloning differentially methylated sequences.
    Toyota M; Issa JP
    Methods Mol Biol; 2002; 200():101-10. PubMed ID: 11951646
    [No Abstract]   [Full Text] [Related]  

  • 43. CpG methylation is targeted to transcription units in an invertebrate genome.
    Suzuki MM; Kerr AR; De Sousa D; Bird A
    Genome Res; 2007 May; 17(5):625-31. PubMed ID: 17420183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale.
    Barrera V; Peinado MA
    Nucleic Acids Res; 2012 Dec; 40(22):11490-8. PubMed ID: 23066096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolutionary evidence suggests that CpG island-associated Alus are frequently unmethylated in human germline.
    Brohede J; Rand KN
    Hum Genet; 2006 May; 119(4):457-8. PubMed ID: 16518638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA methylation determines nucleosome occupancy in the 5'-CpG islands of tumor suppressor genes.
    Portela A; Liz J; Nogales V; Setién F; Villanueva A; Esteller M
    Oncogene; 2013 Nov; 32(47):5421-8. PubMed ID: 23686312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CpG island hypermethylation in human astrocytomas.
    Wu X; Rauch TA; Zhong X; Bennett WP; Latif F; Krex D; Pfeifer GP
    Cancer Res; 2010 Apr; 70(7):2718-27. PubMed ID: 20233874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.
    Patel SA; Graunke DM; Pieper RO
    Mol Cell Biol; 1997 Oct; 17(10):5813-22. PubMed ID: 9315639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA motifs associated with aberrant CpG island methylation.
    Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
    Genomics; 2006 May; 87(5):572-9. PubMed ID: 16487676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilization of epigenetic states of CpG islands by local cooperation.
    Sormani G; Haerter JO; Lövkvist C; Sneppen K
    Mol Biosyst; 2016 Jun; 12(7):2142-6. PubMed ID: 26923344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of CpG island methylation status by integrating DNA physicochemical properties.
    Feng P; Chen W; Lin H
    Genomics; 2014 Oct; 104(4):229-33. PubMed ID: 25172426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
    Shen Y; Chow J; Wang Z; Fan G
    Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CpG islands in human ZFX and ZFY and mouse Zfx genes: sequence similarities and methylation differences.
    Luoh SW; Jegalian K; Lee A; Chen EY; Ridley A; Page DC
    Genomics; 1995 Sep; 29(2):353-63. PubMed ID: 8666382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific methylation status of the entire CpG island is not a prerequisite for the formation of an inactive chromatin at the promoter region in cancer cells.
    Koizume S; Sekiya T; Shiraishi M
    Biol Pharm Bull; 2003 Jan; 26(1):127-8. PubMed ID: 12520191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.
    Vrba L; Jensen TJ; Garbe JC; Heimark RL; Cress AE; Dickinson S; Stampfer MR; Futscher BW
    PLoS One; 2010 Jan; 5(1):e8697. PubMed ID: 20084174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms.
    Turner JD; Pelascini LP; Macedo JA; Muller CP
    Nucleic Acids Res; 2008 Dec; 36(22):7207-18. PubMed ID: 19004867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CpG islands as genomic footprints of promoters that are associated with replication origins.
    Antequera F; Bird A
    Curr Biol; 1999 Sep; 9(17):R661-7. PubMed ID: 10508580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
    McCabe MT; Lee EK; Vertino PM
    Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolutionary Transition of Promoter and Gene Body DNA Methylation across Invertebrate-Vertebrate Boundary.
    Keller TE; Han P; Yi SV
    Mol Biol Evol; 2016 Apr; 33(4):1019-28. PubMed ID: 26715626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA G-quadruplex stability, position and chromatin accessibility are associated with CpG island methylation.
    Jara-Espejo M; Line SR
    FEBS J; 2020 Feb; 287(3):483-495. PubMed ID: 31532882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.